Articles

The Inhibitory Effects of Curcumin Glucuronide on p300-HAT Activity and Hypertrophic Phenylephrine-Induced Responses in Cardiomyocytes

Citation:

European Cardiology Review 2017;12(2):107.

Effects of Pharmacotherapy for Smoking Cessation on LOX Index, a Cardiovascular Risk Marker

Citation:

European Cardiology Review 2017;12(2):96.

Does Angiotensin Receptor Neprilysin Inhibitor (ARNI) Improve Functional Capacity Assessed by 6 Minutes Walking Test?

Citation:

European Cardiology Review 2017;12(2):100.

Cardiac Resynchronization is Associated with Reduction in the Rate of ICD Therapies, While Improves Ventricular Function

Citation:

European Cardiology Review 2017;12(2):93.

Nobiletin a Citrus Flavonoid, Exerts Additional Effects with Angiotensin II Receptor Blocker on Systolic Function in Salt-sensitive Dahl Rats

Citation:

European Cardiology Review 2017;12(2):92.

5-Year Outcomes After Implementation of Optimal Medical Therapy in General Practice Using Liaison Critical Pathway for Secondary Prevention of Coronary Artery Disease: An Observational Study

Citation:

European Cardiology Review 2017;12(2):98.

Cardiovascular Risk Management Targeting Inflammation in Addition to Lipid-lowering Therapy

Citation:

European Cardiology Review 2017;12(2):88

Impact on Patient Care: The 2016 European Heart Failure Guidelines

Citation:

European Cardiology Review 2017;12(2):78–9

Foreword

Citation:

European Cardiology Review 2017;12(2):75